Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Wetzel, H' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 67 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dahmen, N; Muller, MJ; Germeyer, S; Rujescu, D; Anghelescu, I; Hiemke, C; Wetzel, H
      Genetic polymorphisms of the dopamine D-2 and D-3 receptor and neurolepticdrug effects in schizophrenic patients

      SCHIZOPHRENIA RESEARCH
    2. Muller, MJ; Szegedi, A; Wetzel, H; Benkert, O
      Depressive factors and their relationships with other symptom domains in schizophrenia, schizoaffective disorder, and psychotic depression

      SCHIZOPHRENIA BULLETIN
    3. Anghelescu, I; Germeyer, S; Muller, MJ; Klawe, C; Singer, P; Dahmen, N; Wetzel, H; Himmerich, H; Szegedi, A
      No association between the dopamine D-2 receptor TaqI A1 allele and earlier age of onset of alcohol dependence according to different specified criteria

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    4. Dahmen, N; Pauly, T; Szegedi, A; Wetzel, H; Anghelescu, I; Ferdinand, K; Hiemke, C
      Adenylyl cyclase activity is increased in younger, but decreased in older,alcoholic patients after detoxification

      ALCOHOL AND ALCOHOLISM
    5. Schlosser, R; Wetzel, H; Dorr, H; Rossbach, W; Hiemke, C; Benkert, O
      Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers

      PSYCHONEUROENDOCRINOLOGY
    6. Szegedi, A; Lorch, B; Scheurich, A; Ruppe, A; Hautzinger, M; Wetzel, H
      Cue exposure in alcohol dependent patients: preliminary evidence for different types of cue reactivity

      JOURNAL OF NEURAL TRANSMISSION
    7. Muller, MJ; Szegedi, A; Wetzel, H; Benkert, O
      Moderate and severe depression gradations for the Montgomery-Asberg Depression Rating Scale

      JOURNAL OF AFFECTIVE DISORDERS
    8. Szegedi, A; Muller, MJ; Himmerich, H; Anghelescu, I; Wetzel, H
      Carbohydrate-deficient transferrin (CDT) and HDL cholesterol (HDL) are highly correlated in male alcohol dependent patients

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    9. Scheurich, A; Muller, MJ; Wetzel, H; Anghelescu, I; Klawe, C; Ruppe, A; Lorch, B; Himmerich, H; Heidenreich, M; Schmid, G; Hautzinger, M; Szegedi, A
      Reliability and validity of the German version of the European Addiction Severity Index (EuropASI)

      JOURNAL OF STUDIES ON ALCOHOL
    10. Muller, MJ; Rossbach, W; Davids, E; Wetzel, H; Benkert, O
      Evaluation of standardized rater training for the Positive and Negative Syndrome Scale (PANSS)

      NERVENARZT
    11. Muller, MM; Wetzel, H
      IFCC Beckman European Conference 1998 - Frontiers in Molecular Basis of Disease: Inflammatory Diseases

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    12. Szegedi, A; Anghelescu, I; Wiesner, J; Schlegel, S; Weigmann, H; Hartter, S; Hiemke, C; Wetzel, H
      Addition of low-dose fluvoxamine to low-dose clozapine monotherapy in schizophrenia: Drug monitoring and tolerability data from a prospective clinical trial

      PHARMACOPSYCHIATRY
    13. Muller, MJ; Grunder, G; Wetzel, H; Muller-Siecheneder, F; Marx-Dannigkeit, P; Benkert, O
      Antipsychotic effects and tolerability of the sigma ligand EMD 57445 (panamesine) and its metabolites in acute schizophrenia: an open clinical trial

      PSYCHIATRY RESEARCH
    14. Wetzel, H
      Piety and brutality in early 19th century German war poems

      WEIMARER BEITRAGE
    15. Muller, MJ; Marx-Dannigkeit, P; Schlosser, R; Wetzel, H; Addington, D; Benkert, O
      The Calgary Depression Rating Scale for Schizophrenia: development and interrater reliability of a German version (CDSS-G)

      JOURNAL OF PSYCHIATRIC RESEARCH
    16. Muller, MJ; Wetzel, H; Szegedi, A; Benkert, O
      Three dimensions of depression in patients with acute psychotic disorders:A replication study

      COMPREHENSIVE PSYCHIATRY
    17. Pauly, T; Dahmen, N; Szegedi, A; Wetzel, H; Bol, GF; Ferdinand, K; Hiemke, C
      Blood ethanol levels and adenylyl cyclase activity in lymphocytes of alcoholic patients

      BIOLOGICAL PSYCHIATRY
    18. Grunder, G; Wetzel, H; Schlosser, R; Anghelescu, I; Hillert, A; Lange, K; Hiemke, C; Benkert, O
      Neuroendocrine response to antipsychotics: Effects of drug type and gender

      BIOLOGICAL PSYCHIATRY
    19. Grunder, G; Muller, MJ; Andreas, J; Heydari, N; Wetzel, H; Schlosser, R; Schlegel, S; Nickel, O; Eissner, D; Benkert, O
      Occupancy of striatal D-2-like dopamine receptors after treatment with thesigma ligand EMD 57445, a putative atypical antipsychotic

      PSYCHOPHARMACOLOGY
    20. ALLGAUER M; SALZER A; WETZEL H
      INDIVIDUAL AND FAMILY-THERAPY - A CASE-STUDY

      System Familie
    21. Anghelescu, I; Szegedi, A; Schlegel, S; Weigmann, H; Hiemke, C; Wetzel, H
      Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    22. MULLER MJ; ROSSBACH W; DANNIGKEIT P; MULLERSIECHENEDER F; SZEGEDI A; WETZEL H
      EVALUATION OF STANDARDIZED RATER TRAINING FOR THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS)

      Schizophrenia research
    23. MULLER MJ; WETZEL H; BENKERT O
      DIFFERENTIAL TREATMENT EFFECTS OF AMISULPRIDE VERSUS FLUPENTIXOL ON LATENT DIMENSIONS OF DEPRESSIVE AND NEGATIVE SYMPTOMS IN ACUTE SCHIZOPHRENIA

      Schizophrenia research
    24. DAVIDS E; GRUNDER G; WETZEL H; BENKERT O
      PHARMACOTHERAPY OF PSYCHIATRIC-DISORDER D URING PREGNANCY AND BREAST-FEEDING

      Fortschritte der Neurologie, Psychiatrie
    25. MULLERSIECHENEDER F; MULLER MJ; HILLERT A; SZEGEDI A; WETZEL H; BENKERT O
      RISPERIDONE VERSUS HALOPERIDOL AND AMITRIPTYLINE IN THE TREATMENT OF PATIENTS WITH A COMBINED PSYCHOTIC AND DEPRESSIVE SYNDROME

      Journal of clinical psychopharmacology
    26. WETZEL H; ANGHELESCU I; SZEGEDI A; WIESNER J; WEIGMANN H; HARTTER S; HIEMKE C
      PHARMACOKINETIC INTERACTIONS OF CLOZAPINE WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS - DIFFERENTIAL-EFFECTS OF FLUVOXAMINE AND PAROXETINEIN A PROSPECTIVE-STUDY

      Journal of clinical psychopharmacology
    27. HARTTER S; WETZEL H; HAMMES E; TORKZADEH M; HIEMKE C
      SERUM CONCENTRATIONS OF FLUVOXAMINE AND CLINICAL EFFECTS - A PROSPECTIVE OPEN CLINICAL-TRIAL

      Pharmacopsychiatry
    28. HARTTER S; WETZEL H; HAMMES E; TORKZADEH M; HIEMKE C
      NONLINEAR PHARMACOKINETICS OF FLUVOXAMINE AND GENDER DIFFERENCES

      Therapeutic drug monitoring
    29. Szegedi, A; Anghelescu, I; Pauly, T; Dahmen, N; Muller, MJ; Wetzel, H; Hiemke, C
      Activity of the adenylyl cyclase in lymphocytes of male alcoholic patientsis state dependent

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    30. WETZEL H
      GRASS,GUNTER - APPROACHING CALCUTTA

      Weimarer Beitrage
    31. MULLER MJ; WETZEL H
      DIMENSIONALITY OF DEPRESSION IN ACUTE SCHIZOPHRENIA - A METHODOLOGICAL STUDY USING THE BECH-RAFAELSEN MELANCHOLIA SCALE (BRMES)

      Journal of Psychiatric Research
    32. SCHUMACHER M; FUNFHAUSEN K; HUSS V; WETZEL H
      INCIDENCE OF GASTRIC AFFECTIONS IN A COUNTRY-LIKE PART OF GERMANY

      Gastroenterology
    33. SCHUMACHER M; WETZEL H; FUNFHAUSEN K; HUSS V
      LONG-TERM FOLLOW-UP AFTER ITALIAN TRIPLE HP-ERADICATION UNDER PRIMARY-CARE CONDITIONS

      Gastroenterology
    34. MULLER MJ; WETZEL H
      IMPROVEMENT OF INTERRATER RELIABILITY OF PANSS ITEMS AND SUBSCALES BYA STANDARDIZED RATER TRAINING

      Acta psychiatrica Scandinavica
    35. WETZEL H; GRUNDER G; HILLERT A; PHILIPP M; GATTAZ WF; SAUER H; ADLER G; SCHRODER J; REIN W; BENKERT O
      AMISULPRIDE VERSUS FLUPENTIXOL IN SCHIZOPHRENIA WITH PREDOMINANTLY POSITIVE SYMPTOMATOLOGY - A DOUBLE-BLIND CONTROLLED-STUDY COMPARING A SELECTIVE D-2-LIKE ANTAGONIST TO A MIXED D-1- D-2-LIKE ANTAGONIST/

      Psychopharmacology
    36. WETZEL H
      YOUR LOVE IS NOT MY LOVE - PROBLEMS IN RE LATIONSHIPS AND SOLUTION MODELS FROM A SYSTEMIC PERSPECTIVE - GERMAN - WELTERENDERLIN,R

      PPmP. Psychotherapie, Psychosomatik, medizinische Psychologie
    37. BENKERT O; GRUNDER G; WETZEL H
      IS THERE AN ADVANTAGE TO VENLAFAXINE IN COMPARISON WITH OTHER ANTIDEPRESSANTS

      Human psychopharmacology
    38. SZEGEDI A; WETZEL H; ANGERSBACH D; DUNBAR GC; SCHWARZE H; PHILIPP M; BENKERT O
      A DOUBLE-BLIND-STUDY COMPARING PAROXETINE AND MAPROTILINE IN DEPRESSED OUTPATIENTS

      Pharmacopsychiatry
    39. PAULY T; SZEGEDI A; DAHMEN N; BOL GF; FERDINAND K; WETZEL H; HIEMKE C
      BLOOD ETHANOL LEVEL AND ADENYLYL-CYCLASE ACTIVITY IN LYMPHOCYTES OF ACTIVELY DRINKING ALCOHOLICS

      European journal of cell biology
    40. SZEGEDI A; WETZEL H; ANGERSBACH D; PHILIPP M; BENKERT O
      RESPONSE TO TREATMENT IN MINOR AND MAJOR DEPRESSION - RESULTS OF A DOUBLE-BLIND COMPARATIVE-STUDY WITH PAROXETINE AND MAPROTILINE

      Journal of affective disorders
    41. GRUNDER G; MULLER M; SCHLEGEL S; WETZEL H; SCHLOSSER R; ANDREAS J; EISSNER D; BENKERT O
      HIGH-DEGREE OF STRIATAL D2-LIKE DOPAMINE-RECEPTOR OCCUPANCY BY THE SIGMA-LIGAND EMD-57445, A PUTATIVE ATYPICAL ANTIPSYCHOTIC

      The Journal of nuclear medicine
    42. BENKERT O; SZEGEDI A; WETZEL H; STAAB HJ; MEISTER W; PHILIPP M
      DOSE-ESCALATION VS CONTINUED DOSES OF PAROXETINE AND MAPROTILINE - A PROSPECTIVE-STUDY IN DEPRESSED OUT-PATIENTS WITH INADEQUATE TREATMENT RESPONSE

      Acta psychiatrica Scandinavica
    43. MANN K; BAUER H; HIEMKE C; ROSCHKE J; WETZEL H; BENKERT O
      ACUTE, SUBCHRONIC AND DISCONTINUATION EFFECTS OF ZOPICLONE ON SLEEP EEG AND NOCTURNAL MELATONIN SECRETION

      European neuropsychopharmacology
    44. MINDLEN F; NORDABY R; RUIZ M; ZAVALA A; GUZMAN L; MARTINEZ F; DIAZ RR; MACKEY C; MARINO M; ROMERO G; ZAPATA G; CUNEO C; KAWAMURA T; COELHO O; MASSAYOCHI O; BRAGA J; LABRUNIE A; BODANESE L; MANENTI E; VITOLA D; NICOLAU J; AMODEO C; ARMAGANIJAN D; BERTOLAMI M; CARAMELI B; CARVALHO A; CIRENZA C; FICHINO M; FRANKEN R; GHORAYEB N; KADRI T; LEAO P; MALHEIROS F; PAVANELLO R; RAMIRES F; RAMIRES J; SAVIOLI F; SOUSA A; TANAJURA L; TOPPS D; KORNER L; MARTINEZ V; BAPTIE B; BASINGER M; BAYLIS B; BERESFORD P; EDWARDS A; GIANNACCARO P; GROENEWOUD Y; GROSE M; KELLEN J; LAM S; LESOWAY R; MA P; MELDRUM D; MITCHELL D; MITCHELL LB; ROTH D; SHUMAK S; SIMON M; STONE J; WARNICA W; WYSE D; NEFFGEN C; NEFFGEN J; ARMSTRONG F; ARMSTRONG W; BELL N; BLACK W; BRASS N; BRENNEIS F; BROWNOFF R; CHAYTORS G; DEBANNE D; DERKSEN C; DONOFF M; DZAVIK V; GOERES M; GREENWOOD P; GULAMHUSEIN S; HUI W; HUTCHISON K; KASIAN L; KASZA L; KRIKKE E; KVILL L; LAKHANI Z; LINKLATER D; MACKEL J; MARTIN S; MONTAGUE T; MOORES D; MUSSEAU A; MUZYKA T; PARADIS J; PROSSER A; RYAN E; SENARATNE M; STENERSON P; TALIBI T; TEO K; YOUNG C; ZUK V; WHITE R; BROWNE K; BROWNE M; HAPPEL K; IRVING A; PLESKO A; DONNELLY R; RADOMSKY N; FELKER P; LARSEN D; MORSE J; ROWNTREE C; THOMPSON J; WEDEL R; BLOOMBERG G; CHOMIN G; DAHL M; LEONG W; MOY V; HEATH J; MARSHALL J; TERWIEL M; KENEFICK G; KURITZKY R; STEVENS K; WEDDINGS K; BARBAN K; IMRIE J; WOO K; ASHTON T; CALVERT K; BISHOP W; SWEENEY R; BREAKWELL L; KORNDER J; PEARCE S; POLASEK P; RICHARDSON P; GHOSH S; RIELLY M; WAGNER K; BEMSTEIN V; DAWSON K; LEE P; LEWIS J; MACDONALD K; MCGEE L; THOMPSON C; HILTON D; ILLOTT K; KLINKE P; MCCONNELL J; MCGEE L; RABKIN S; ONG A; ONG G; BEDARD D; HOESCHEN R; MEHTA P; MOHAMMAD I; MORRIS A; BESSOUDO R; DOBBINS N; MCLELLAN L; MILTON J; DAVIS R; OKEEFE D; SMITH R; JOYCE C; PARSONS M; SKANES J; SUSSEX B; TOBINI M; RAVALIA M; SHERMAN G; WORRALL G; ATKINSON A; HATHEWAY R; JOHNSON B; BARNHILL S; BATA I; COSSEET J; JOHNSTONE D; MACFARLANE M; SHERIDAN W; CROSSMAN L; FOLKINS D; SHIRLEY M; MACHEL T; MORASH J; GUPTA M; MAYICH M; VAKANI T; BAITZ T; MACPHEE E; TURTON E; TURTON M; CHAN N; MISTERSKI J; RACO D; CURNEW G; FALLEN E; FINKELSTEIN L; GERSTEIN H; HARDMAN P; LAWAND S; LONN E; MAGI W; MCQUEEN M; PANJU A; PATTERSON R; SULLIVAN B; SULLIVAN H; SULLIVAN M; TAYLOR K; WORRON I; YUSUF S; CAMERON W; NOSEWORTHY C; HOULDEN R; LAVALLE T; FOWLIS R; JANZEN I; ARNOLD M; CANN M; CARROLL S; DUMARESQ S; EDMONDS M; FURLONG P; GEDDES C; GRAHAM E; HARRIS K; HRAMIAK I; KENNEDY R; KOSTUK W; KRUPA M; LENT B; LOVELL M; MACLEAN C; MASSEL D; MCMANUS R; MCSHERRY J; MUNOZ C; OCCHIPINTI J; OOSTERVELD L; PFLUGFELDER P; POWERS S; SOUTHERN R; SPENCE D; SQUIRES P; WETMORE S; WILLING J; WISENBERG G; WOLFE B; KANNAMPUZHA P; REBANE T; SLUZAR V; HESS A; CHAN Y; THOMSON D; BAIGRIE R; DUBBIN J; LIUNI C; TAN KW; BRANKSTON E; HEWSON P; HRYCYSHYN B; KAPUSTA W; KNOX L; LOCKNER C; WHITSITT P; BAIRD M; CONROY D; DAVIES RA; DAVIES RF; FRASER M; HAGAR S; HIERLIHY P; KEELY E; KHAN S; LAU DGW; MAROIS L; NEMETH K; REEVES E; TUREK M; VEXLER R; YOUNG D; KUMAR G; KURUVILLA G; KURUVILLA P; LOWE D; KWOK K; BLAKELY J; STYLING S; BOZEK B; CHARLES J; FELL D; FELL DA; GOODE E; GROSSMAN LD; MATTHEWS E; NITKIN R; RICCI J; SELBY A; SINGH N; SWAN J; EMMETT J; WEINGERT M; BAIGRIE R; GANJAVI F; HILL D; NAWAZ S; HESSIAN R; KWIATKOWSKI K; LAI C; MULAISHO C; OKEEFE H; SMITH H; WEEKS A; ANDREWS J; BARNIE A; DROBAC M; HACKER P; HANNA A; IWANOCHKO M; KENSHOLE A; LANGER A; LIU P; MACLEAN S; MOE G; SASSON Z; STERNBERG L; TRACHUK C; WALTERS J; ZINMAN B; CHEUNG M; CINA C; YAO L; MAN K; FULOP J; GLANZ A; SIBBICK M; CARTER P; OOSTERVELD L; HICKEY J; MCMILLIAN E; DION D; STHILAIRE R; COUTU D; DAMOURS G; STARRA R; BROOKS J; DECHAMPS P; KIWAN G; KOUZ S; LAFOREST M; REMILLARD C; BELLAMY D; BROSSOIT R; CARRIER S; HOUDE A; LABONTE I; BELANGER A; KANDALAFT N; QUENNEVILLE L; SANDI M; AUGER P; BILODEAU N; DELAGE F; DUMONT F; GIROUX R; LOISEL R; POIRIER C; SAULNIER D; CARMICHAEL P; LEMAY C; LENIS J; ARISJILWAN N; BEDARD H; CASAVANT C; CHIASSON J; DAGENAIS D; FITCHETT D; GOSSARD D; HALLE H; HAMEL N; JOYAL M; MAGNAN O; METHE M; PEDNEAULT L; PILON C; POISSON D; PRIMEAU L; RONDEAU C; ROY C; RUEL M; SERPA A; SESTIER F; SMILOVITCH M; THEROUX P; BEAUDOIN J; BOUDREAULT JR; DAMOURS D; DOUVILLE T; GIGUERE G; HOUDE G; LABBE R; LACHANCE S; LESSARD L; MERCIER G; NOEL HP; TALBOT P; TREMBLAY J; KARABATSOS A; MACLELLAN K; WILSON P; BOGATY P; LAFORGE D; LANGLAIS M; LEBLANC M; SAMSON M; TURCOTTE J; CAMPEAU J; DUPUIS R; LAUZON C; OUIMET F; PRUNEAU G; DESMARIS C; FRECHETTO I; GERVAIS P; BROPHY J; LEROUX S; BESTER S; MEUNIER L; SAYEED M; HART M; MOUMNE I; THOMASSE G; WALKER J; WALKER M; AHMED S; HABIB NM; HABIB NM; KUNY P; LOPEZ J; KLEIN W; GRISOLD M; HEYNDRICKX L; FIASSE A; DEGAUTE JP; MOCKEL J; DUPREZ D; CHAUDRON JM; BODSON A; KRZENTOWSKI G; BOLAND J; KOLENDORF K; WINTHER B; JUHL H; HAMALAINEN T; SIITONEN O; GIN H; RIGALLEAU V; HENSEN J; RIEL R; OEHMENBRITSCH R; SCHULZESCHLEPPINGHOFF B; HOPF R; MOLLER A; ROSAK C; WETZEL H; HASSLACHER C; MARTIN T; STEIN J; ERDMANN E; BOHM M; HARTMANN D; BREIDERT M; FRITZEN R; SCHERBAUM W; MANN J; MAUS J; SCHROEDER C; HENRICHS H; UNGER H; ICKENSTEIN G; KROMER E; RIEGGER G; SCHUNKERT H; BASAN B; HAMPEL R; CREAN P; GARADAH T; WHITE U; MARINI N; PACIARONI E; SACCOMANO G
      THE HOPE (HEART OUTCOMES PREVENTION EVALUATION) STUDY - THE DESIGN OFA LARGE, SIMPLE RANDOMIZED TRIAL OF AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR (RAMIPRIL) AND VITAMIN-E IN PATIENTS AT HIGH-RISK OF CARDIOVASCULAR EVENTS

      Canadian journal of cardiology
    45. BENKERT O; SZEGEDI A; WETZEL H
      MINIMUM EFFECTIVE DOSE FOR ANTIDEPRESSANTS - AN OBLIGATORY REQUIREMENT FOR ANTIDEPRESSANT DRUG-EVALUATION

      International clinical psychopharmacology
    46. GRUNDER G; WETZEL H; SCHLOSSER R; BENKERT O
      SUBCHRONIC ANTIDEPRESSANT TREATMENT WITH VENLAFAXINE OR IMIPRAMINE AND EFFECTS ON BLOOD-PRESSURE AND HEART-RATE - ASSESSMENT BY AUTOMATIC 24-HOUR MONITORING

      Pharmacopsychiatry
    47. SZEGEDI A; WETZEL H; LEAL M; HARTTER S; HIEMKE C
      COMBINATION TREATMENT WITH CLOMIPRAMINE AND FLUVOXAMINE - DRUG-MONITORING, SAFETY, AND TOLERABILITY DATA

      The Journal of clinical psychiatry
    48. WETZEL H
      WORKS, JOURNALS, LETTERS - GERMAN - MULLE R,W

      Seminar (Toronto)
    49. WETZEL H
      TRAKL,GEORG - A BIOGRAPHY WITH PICTURES, TEXTS, AND DOCUMENTS - GERMAN - WEICHSELBAUM,H

      Seminar (Toronto)
    50. SCHLEICHER H; STRUSZCZYK H; WETZEL H
      CHANGES OF STRUCTURE AND PROPERTIES OF CE LLULOSE BY ENZYMATIC TREATMENT

      Das Papier
    51. BENKERT O; GRUNDER G; WETZEL H; HACKETT D
      A RANDOMIZED, DOUBLE-BLIND COMPARISON OF A RAPIDLY ESCALATING DOSE OFVENLAFAXINE AND IMIPRAMINE IN INPATIENTS WITH MAJOR DEPRESSION AND MELANCHOLIA

      Journal of Psychiatric Research
    52. STREHMEL V; WETZEL H; STREHMEL B
      ATTACHING OF FLEXIBLE CHAINS TO NOVOLACS ON THE BASIS OF BISPHENOL-A

      Journal of applied polymer science
    53. MOLLER A; WETZEL H; NIEMOLLER E; HOPF R
      PURULENT PERICARDIAL-EFFUSION WITH TAMPON ADE, A RARE INITIAL MANIFESTATION OF PNEUMOCOCCAL INFECTION

      Deutsche Medizinische Wochenschrift
    54. WETZEL H
      TRANSPORTATION OF REFERENCE MATERIAL

      European journal of clinical chemistry and clinical biochemistry
    55. PALMIE S; HELLER M; WETZEL H
      PTA AND STENT PLACEMENT IN VENA-CAVA-SUPE RIOR SYNDROME UNDER TEMPORARY SALVAGE OF A PORTAL-VEIN SYSTEM

      RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren
    56. BENKERT O; MULLERSIECHENEDER F; WETZEL H
      DOPAMINE AGONISTS IN SCHIZOPHRENIA - A REVIEW

      European neuropsychopharmacology
    57. SCHIMMING CG; METTE R; REICHE EW; SCHRAUTZER J; WETZEL H
      NITROGEN FLUXES IN A TYPICAL AGROECOSYSTE M IN SCHLESWIG-HOLSTEIN - MEASUREMENTS, BUDGETS, MODEL VALIDATION

      Zeitschrift fur Pflanzenernahrung und Bodenkunde
    58. GERBALDO H; FICKINGER MP; WETZEL H; HELISCH A; PHILIPP M; BENKERT O
      PRIMARY ENDURING NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND MAJOR DEPRESSION

      Journal of Psychiatric Research
    59. WETZEL H; SZEGEDI A; HAIN C; WIESNER J; SCHLEGEL S; BENKERT O
      SEROQUEL (ICI-204-636), A PUTATIVE ATYPICAL ANTIPSYCHOTIC, IN SCHIZOPHRENIA WITH POSITIVE SYMPTOMATOLOGY - RESULTS OF AN OPEN CLINICAL-TRIAL AND CHANGES OF NEUROENDOCRINOLOGICAL AND EEG PARAMETERS

      Psychopharmacology
    60. GRUNDER G; WETZEL H; HILLERT A; JOCHUM E; HIEMKE C; BENKERT O
      THE NEUROENDOCRINOLOGICAL PROFILE OF ROXINDOLE, A DOPAMINE AUTORECEPTOR AGONIST, IN SCHIZOPHRENIC-PATIENTS

      Psychopharmacology
    61. HIEMKE C; WEIGMANN H; HARTTER S; DAHMEN N; WETZEL H; MULLER H
      ELEVATED LEVELS OF CLOZAPINE IN SERUM AFTER ADDITION OF FLUVOXAMINE

      Journal of clinical psychopharmacology
    62. SEILER W; WETZEL H; HILLERT A; SCHOLLNHAMMER G; BENKERT O; HIEMKE C
      PLASMA-LEVELS OF BENPERIDOL, PROLACTIN, AND HOMOVANILLIC-ACID AFTER INTRAVENOUS VERSUS 2 DIFFERENT KINDS OF ORAL APPLICATION OF THE NEUROLEPTIC IN SCHIZOPHRENIC-PATIENTS

      Experimental and clinical endocrinology
    63. WETZEL H; WIESNER J; HIEMKE C; BENKERT O
      ACUTE ANTAGONISM OF DOPAMINE D-2-LIKE RECEPTORS BY AMISULPRIDE - EFFECTS ON HORMONE-SECRETION IN HEALTHY-VOLUNTEERS

      Journal of Psychiatric Research
    64. WETZEL H; HILLERT A; GRUNDER G; BENKERT O
      ROXINDOLE, A DOPAMINE AUTORECEPTOR AGONIST, IN THE TREATMENT OF POSITIVE AND NEGATIVE SCHIZOPHRENIC SYMPTOMS

      The American journal of psychiatry
    65. SEILER W; WETZEL H; HILLERT A; SCHOLLNHAMMER G; LANGER M; BARLAGE U; HIEMKE C
      PHARMACOKINETICS AND BIOAVAILABILITY OF BENPERIDOL IN SCHIZOPHRENIC-PATIENTS AFTER INTRAVENOUS AND 2 DIFFERENT KINDS OF ORAL APPLICATION

      Psychopharmacology
    66. WETZEL H; BENKERT O
      DOPAMINE AUTORECEPTOR AGONISTS IN THE TREATMENT OF SCHIZOPHRENIC DISORDERS

      Progress in neuro-psychopharmacology & biological psychiatry
    67. BENKERT O; WETZEL H; SZEGEDI A
      SEROTONIN DYSFUNCTION SYNDROMES - A FUNCTIONAL COMMON DENOMINATOR FORCLASSIFICATION OF DEPRESSION, ANXIETY, AND OBSESSIVE-COMPULSIVE DISORDER

      International clinical psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/02/20 alle ore 03:34:08